Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12983)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 28, 2017 (publication date) through Apr 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hernández-Aquino E, Zarco N, Casas-Grajales S, Ramos-Tovar E, Flores-Beltrán RE, Arauz J, Shibayama M, Favari L, Tsutsumi V, Segovia J, Muriel P. Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways. World J Gastroenterol 2017; 23(24): 4354-4368 [PMID: 28706418 DOI: 10.3748/wjg.v23.i24.4354] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i24/4354.htm |
| Number | Citing Articles |
| 1 |
Michaelle Chokki, Mihaela Cudălbeanu, Cheikna Zongo, Durand Dah-Nouvlessounon, Ioana Otilia Ghinea, Bianca Furdui, Robert Raclea, Aly Savadogo, Lamine Baba-Moussa, Sorin Marius Avamescu, Rodica Mihaela Dinica, Farid Baba-Moussa. Exploring Antioxidant and Enzymes (A-Amylase and B-Glucosidase) Inhibitory Activity of Morinda lucida and Momordica charantia Leaves from Benin. Foods 2020; 9(4): 434 doi: 10.3390/foods9040434
|
| 2 |
Fan Yang, Shenghe Hu, Xun Sheng, Yu Liu. Naringenin loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in hepatic fibrosis. Biomedical Microdevices 2020; 22(4) doi: 10.1007/s10544-020-00524-1
|
| 3 |
Jianzhi Wu, Guangrui Huang, Yajing Li, Xiaojiaoyang Li. Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases. Chinese Medicine 2020; 15(1) doi: 10.1186/s13020-020-00371-5
|
| 4 |
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial. International Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14852
|
| 5 |
Zhu Wenbo, Han Jianwei, Liu Hua, Tang Lei, Chen Guijuan, Tian Mengfei. The potential of flavonoids in hepatic fibrosis: A comprehensive review. Phytomedicine 2024; 133: 155932 doi: 10.1016/j.phymed.2024.155932
|
| 6 |
Yi Qiao Hua, Yi Zeng, Jin Xu, Xiao Le Xu. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe−/−mice: role of SIRT1. Phytomedicine 2021; 81: 153412 doi: 10.1016/j.phymed.2020.153412
|
| 7 |
Tao Xu, Linxin Pan, Liangyun Li, Shuang Hu, Hong Zhou, Chenchen Yang, Junfa Yang, Haodong Li, Yuming Liu, Xiaoming Meng, Jun Li. MicroRNA‐708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88. Journal of Cellular and Molecular Medicine 2020; 24(13): 7127 doi: 10.1111/jcmm.15119
|
| 8 |
Beatriz Cicuéndez, Irene Ruiz-Garrido, Alfonso Mora, Guadalupe Sabio. Stress kinases in the development of liver steatosis and hepatocellular carcinoma. Molecular Metabolism 2021; 50: 101190 doi: 10.1016/j.molmet.2021.101190
|
| 9 |
Azher Arafah, Muneeb U. Rehman, Tahir Maqbool Mir, Adil Farooq Wali, Rayeesa Ali, Wajhul Qamar, Rehan Khan, Ajaz Ahmad, Syed Sameer Aga, Saeed Alqahtani, Nada M. Almatroudi. Multi-Therapeutic Potential of Naringenin (4′,5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms. Plants 2020; 9(12): 1784 doi: 10.3390/plants9121784
|
| 10 |
Eduardo E. Vargas-Pozada, Pablo Muriel. Herbal medicines for the liver: from bench to bedside. European Journal of Gastroenterology & Hepatology 2020; 32(2): 148 doi: 10.1097/MEG.0000000000001485
|
| 11 |
Jia-jia Du, Jia-chang Sun, Nan Li, Xiu-qin Li, Wu-yi Sun, Wei Wei. β-Arrestin2 deficiency attenuates oxidative stress in mouse hepatic fibrosis through modulation of NOX4. Acta Pharmacologica Sinica 2021; 42(7): 1090 doi: 10.1038/s41401-020-00545-9
|
| 12 |
A. Ramadan, Nehal Afifi, Nemat Z. Yassin, Rehab F. Abdel-Rahman, Sahar S. Abd El-Rahman, Hany M. Fayed. Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats. Chemico-Biological Interactions 2018; 289: 109 doi: 10.1016/j.cbi.2018.05.002
|
| 13 |
|
| 14 |
Karim Naraki, Ramin Rezaee, Gholamreza Karimi. A review on the protective effects of naringenin against natural and chemical toxic agents. Phytotherapy Research 2021; 35(8): 4075 doi: 10.1002/ptr.7071
|
| 15 |
Vasudevan Sekar, Venkateish VP, Vani Vijay, Annapoorna BR, Nivya Vijayan, Madan Kumar Perumal. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action. Journal of Food Science and Technology 2024; 61(11): 2046 doi: 10.1007/s13197-024-06002-3
|
| 16 |
Manal A. Alfwuaires, Ademola C. Famurewa, Abdulmohsen I. Algefare, Azza Sedky. Naringenin blocks hepatic cadmium accumulation and suppresses cadmium-induced hepatotoxicity via amelioration of oxidative inflammatory signaling and apoptosis in rats. Drug and Chemical Toxicology 2024; 47(4): 436 doi: 10.1080/01480545.2023.2196377
|
| 17 |
Yuan Zhou, Rong Wu, Fei-fei Cai, Wen-Jun Zhou, Yi-Yu Lu, Hui Zhang, Qi-Long Chen, Ming-Yu Sun, Shi-Bing Su. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis. Pharmaceutical Biology 2021; 59(1): 1592 doi: 10.1080/13880209.2021.1999275
|
| 18 |
Pablo Muriel. Fighting liver fibrosis to reduce mortality associated with chronic liver diseases: The importance of new molecular targets and biomarkers. EBioMedicine 2019; 40: 35 doi: 10.1016/j.ebiom.2019.02.002
|
| 19 |
Aida Doostkam, Hossein Mirkhani, Kamyar Iravani, Saied Karbalay-Doust, Kazem Zarei. Effect of Rutin on Diabetic Auditory Neuropathy in an Experimental Rat Model. Clinical and Experimental Otorhinolaryngology 2021; 14(3): 259 doi: 10.21053/ceo.2019.02068
|
| 20 |
Linda Vanessa Márquez-Quiroga, Aline Barboza-López, Jose Y. Suárez-Castillo, Irina Cardoso-Lezama, Miguel Á. Fuentes-Figueroa, Eduardo E. Vargas-Pozada, Juan D. Rodriguez-Callejas, Erika Ramos-Tovar, Carolina Piña-Vázquez, Jaime Arellanes-Robledo, Saúl Villa-Treviño, Pablo Muriel. Naringenin attenuates early hepatocarcinogenesis induced by a MASH model. Annals of Hepatology 2025; : 101897 doi: 10.1016/j.aohep.2025.101897
|
| 21 |
Hong Zhang, Mengyi Chi, Yaxian Wang, Linlin Chen, Xipeng Sun, Lili Wan, Quanjun Yang, Cheng Guo. Naringenin alleviates cisplatin induced muscle atrophy by regulating RIPK1/AMPK/NF-κB pathway. Journal of Functional Foods 2021; 86: 104714 doi: 10.1016/j.jff.2021.104714
|
| 22 |
Hongshuai Liu, Yufei Li, Yan Jin, Xin Li, Dongxian Wang, Xiaowen Yu, Zhenyuan Jiang, Guoliang Yin, Suwen Chen, Xin Zhang, Decheng Meng, Wenfei Yu, Wenyin Jiang, Fengxia Zhang. Effects of different natural products in patients with non‐alcoholic fatty liver disease—A network meta‐analysis of randomized controlled trials. Phytotherapy Research 2024; 38(7): 3801 doi: 10.1002/ptr.8182
|
| 23 |
Xiaoying Li, Saifei Li, Ningning Li. Research Progress on Natural Products Alleviating Liver Inflammation and Fibrosis via NF‐κB Pathway. Chemistry & Biodiversity 2025; doi: 10.1002/cbdv.202402248
|
| 24 |
Zuhal UÇKUN ŞAHİNOĞULLARI, Sevda GÜZEL, Necmiye CANACANKATAN, Cem YALAZA, Deniz KİBAR, Gulsen BAYRAK. Naringenin Reduces Hepatic Inflammation and Apoptosis Induced by Vancomycin in Rats. Clinical and Experimental Health Sciences 2021; 11(2): 191 doi: 10.33808/clinexphealthsci.741916
|
| 25 |
Erika Ramos-Tovar, Pablo Muriel. Dietary Interventions in Liver Disease. 2019; : 101 doi: 10.1016/B978-0-12-814466-4.00009-4
|
| 26 |
Luca Massaro, Anna Raguzzini, Paola Aiello, Débora Villaño Valencia. The Potential Role of Naringin and Naringenin as Nutraceuticals Against
Metabolic Syndrome. Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23(4): 428 doi: 10.2174/1871530322666220827141203
|
| 27 |
G.I. Anuja, V.J. Shine, P.G. Latha, S.R. Suja. Protective effect of ethyl acetate fraction of Drynaria quercifolia against CCl 4 induced rat liver fibrosis via Nrf2/ARE and NFκB signalling pathway. Journal of Ethnopharmacology 2018; 216: 79 doi: 10.1016/j.jep.2017.11.015
|
| 28 |
Erika Hernández-Aquino, Pablo Muriel. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World Journal of Gastroenterology 2018; 24(16): 1679-1707 doi: 10.3748/wjg.v24.i16.1679
|
| 29 |
Yuan Zhou, Rong Wu, Fei-Fei Cai, Wen-Jun Zhou, Yi-Yu Lu, Hui Zhang, Qi-Long Chen, Shi-Bing Su. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis. Journal of Ethnopharmacology 2021; 264: 113021 doi: 10.1016/j.jep.2020.113021
|
| 30 |
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020; 9(4): 875 doi: 10.3390/cells9040875
|
| 31 |
Rehab F. Abdel-Rahman, Hany M. Fayed, Gihan F. Asaad, Hanan A. Ogaly, Alyaa F. Hessin, Abeer A. A. Salama, Sahar S. Abd El-Rahman, Mahmoud S. Arbid, Marawan Abd Elbaset Mohamed, Yasmina Abd‐Elhakim. The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats. PLOS ONE 2021; 16(12): e0260130 doi: 10.1371/journal.pone.0260130
|
| 32 |
Liang Shan, Zhenni Liu, Leilei Ci, Chen Shuai, Xiongwen Lv, Jun Li. Research progress on the anti-hepatic fibrosis action and mechanism of natural products. International Immunopharmacology 2019; 75: 105765 doi: 10.1016/j.intimp.2019.105765
|
| 33 |
Erika Hernández-Aquino, Marco A. Quezada-Ramírez, Angélica Silva-Olivares, Sael Casas-Grajales, Erika Ramos-Tovar, Rosa E. Flores-Beltrán, José Segovia, Mineko Shibayama, Pablo Muriel. Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways. European Journal of Pharmacology 2019; 865: 172730 doi: 10.1016/j.ejphar.2019.172730
|
| 34 |
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Víctor Tsutsumi, Pablo Muriel. Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways. Annals of Hepatology 2022; 27(2): 100671 doi: 10.1016/j.aohep.2022.100671
|
| 35 |
Erika Ramos-Tovar, Rosa E. Flores-Beltrán, Silvia Galindo-Gómez, Javier Camacho, Víctor Tsutsumi, Pablo Muriel. An aqueous extract of Stevia rebaudiana variety Morita II prevents liver damage in a rat model of cirrhosis that mimics the human disease. Annals of Hepatology 2019; 18(3): 472 doi: 10.1016/j.aohep.2018.10.002
|
| 36 |
Xiaoqi Pan, Xiao Ma, Yinxiao Jiang, Jianxia Wen, Lian Yang, Dayi Chen, Xiaoyu Cao, Cheng Peng, Hongwei Zhang. A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/7171498
|
| 37 |
Salma M. Eraky, Dalia H. El-Kashef, Mohamed El-Sherbiny, Nada F. Abo El-Magd. Naringenin mitigates thioacetamide-induced hepatic encephalopathy in rats: targeting the JNK/Bax/caspase-8 apoptotic pathway. Food & Function 2023; 14(2): 1248 doi: 10.1039/D2FO03470K
|
| 38 |
Zehra Calis, Dervis Dasdelen, Abdulkerim Kasim Baltaci, Rasim Mogulkoc. Naringenin Prevents Inflammation, Apoptosis, and DNA Damage in Potassium Oxonate-Induced Hyperuricemia in Rat Liver Tissue: Roles of Cytochrome C, NF-κB, Caspase-3, and 8-Hydroxydeoxyguanosine. Metabolic Syndrome and Related Disorders 2022; 20(8): 473 doi: 10.1089/met.2022.0028
|
| 39 |
Sarita Solanki, Himangi Vig, Nidhi Khatri, Bhanu Pratap Singh, Mohammad Shahid Khan, Manish Devgun, Pranay Wal, Ankita Wal. Naringenin: A Promising Immunomodulator for Anti-inflammatory, Neuroprotective and Anti-cancer Applications. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2025; 24(1): 1 doi: 10.2174/0118715230320007240708074939
|
| 40 |
Zhongwei Liu, Shuang Shi, Haitao Zhu, Yunfei Chen, Yong Zhang, Zhenzhong Zheng, Xi Wang. Novel ASK1 Inhibitor AGI-1067 Attenuates AGE-Induced Fibrotic Response by Suppressing the MKKs/p38 MAPK Pathway in Human Coronary Arterial Smooth Muscle Cells. International Heart Journal 2018; 59(6): 1416 doi: 10.1536/ihj.17-625
|
| 41 |
Zhe Meng, Hai-yu Li, Chun-ying Si, Yu-zhou Liu, Shuai Teng. Asiatic acid inhibits cardiac fibrosis throughNrf2/HO-1 and TGF-β1/Smads signaling pathways in spontaneous hypertension rats. International Immunopharmacology 2019; 74: 105712 doi: 10.1016/j.intimp.2019.105712
|
| 42 |
Liang Shan, Fengling Wang, Dandan Zhai, Xiangyun Meng, Jianjun Liu, Xiongwen Lv. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomedicine & Pharmacotherapy 2023; 161: 114472 doi: 10.1016/j.biopha.2023.114472
|
| 43 |
Lorena Rosas-Martínez, Rafael Rodríguez-Muñoz, María del Carmen Namorado-Tonix, Fanis Missirlis, Leonardo del Valle-Mondragón, Alicia Sánchez-Mendoza, José L. Reyes-Sánchez, Luz Graciela Cervantes-Pérez. Peroxisome Proliferator-Activated Receptor Alpha Stimulation Preserves Renal Tight Junction Components in a Rat Model of Early-Stage Diabetic Nephropathy. International Journal of Molecular Sciences 2024; 25(23): 13152 doi: 10.3390/ijms252313152
|
| 44 |
Hongjuan He, Xiaoyan Ji, Lihua Cao, Zhenzhen Wang, Xiaoyu Wang, Xiu-Min Li, Mingsan Miao, Alexandru Corlateanu. Medicine Targeting Epithelial-Mesenchymal Transition to Treat Airway Remodeling and Pulmonary Fibrosis Progression. Canadian Respiratory Journal 2023; 2023: 1 doi: 10.1155/2023/3291957
|
| 45 |
Wen-Qing Li, Wen-Hao Liu, Die Qian, Jia Liu, Shi-Qiong Zhou, Lei Zhang, Wei Peng, Li Su, Hong Zhang. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.962525
|
| 46 |
Erika Ramos‐Tovar, Rosa E. Flores‐Beltrán, Silvia Galindo‐Gómez, Eunice Vera‐Aguilar, Araceli Diaz‐Ruiz, Sergio Montes, Javier Camacho, Víctor Tsutsumi, Pablo Muriel. Stevia rebaudianatea prevents experimental cirrhosis via regulation of NF‐κB, Nrf2, transforming growth factor beta, Smad7, and hepatic stellate cell activation. Phytotherapy Research 2018; 32(12): 2568 doi: 10.1002/ptr.6197
|
| 47 |
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Advances in Nutrition 2021; 12(2): 413 doi: 10.1093/advances/nmaa106
|
| 48 |
Shuwei Ke, Qingyuan Hu, Guanyao Zhu, Linghuan Li, Xuechao Sun, Hongbin Cheng, Lingqiao Li, Yuanfa Yao, Hanbing Li. Remodeling of white adipose tissue microenvironment against obesity by phytochemicals. Phytotherapy Research 2024; 38(10): 4904 doi: 10.1002/ptr.7758
|
| 49 |
Ali Noorafshan, Maedeh Hashemi, Saied Karbalay-Doust, Fatemeh Karimi. High dose Allura Red, rather than the ADI dose, induces structural and behavioral changes in the medial prefrontal cortex of rats and taurine can protect it. Acta Histochemica 2018; 120(6): 586 doi: 10.1016/j.acthis.2018.07.004
|
| 50 |
Erika Ramos‐Tovar, Laura D. Buendia‐Montaño, Silvia Galindo‐Gómez, Erika Hernández‐Aquino, Víctor Tsutsumi, Pablo Muriel. Stevia prevents experimental cirrhosis by reducing hepatic myofibroblasts and modulating molecular profibrotic pathways. Hepatology Research 2019; 49(2): 212 doi: 10.1111/hepr.13275
|
| 51 |
Ankit Chowdhury, Papiya Mitra Mazumder. Unlocking the potential of flavonoid-infused drug delivery systems for diabetic wound healing with a mechanistic exploration. Inflammopharmacology 2024; 32(5): 2861 doi: 10.1007/s10787-024-01561-5
|
| 52 |
Shiva Roshankhah, Amir Abdolmaleki, Mohammad Reza Salahshoor. Reduction of Renal Ischemia-Reperfusion-Induced Liver Side Effects in Rats through Antioxidative Properties of Narigenin. Journal of Advances in Medical and Biomedical Research 2021; 29(132): 46 doi: 10.30699/jambs.29.132.46
|
| 53 |
Alina Ciceu, Ferenc Fenyvesi, Anca Hermenean, Simona Ardelean, Simona Dumitra, Monica Puticiu. Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: Molecular Mechanisms and Nanoparticulate Drug Delivery Systems. International Journal of Molecular Sciences 2024; 25(17): 9346 doi: 10.3390/ijms25179346
|
| 54 |
Lara Testai, Eugenia Piragine, Ilaria Piano, Lorenzo Flori, Eleonora Da Pozzo, Vincenzo Miragliotta, Andrea Pirone, Valentina Citi, Lorenzo Di Cesare Mannelli, Simone Brogi, Sara Carpi, Alma Martelli, Paola Nieri, Claudia Martini, Carla Ghelardini, Claudia Gargini, Vincenzo Calderone. The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/4650207
|
| 55 |
Moisés Martínez-Castillo, Judith Pacheco-Yepez, Nadia Flores-Huerta, Paula Guzmán-Téllez, Rosa A. Jarillo-Luna, Luz M. Cárdenas-Jaramillo, Rafael Campos-Rodríguez, Mineko Shibayama. Flavonoids as a Natural Treatment Against Entamoeba histolytica. Frontiers in Cellular and Infection Microbiology 2018; 8 doi: 10.3389/fcimb.2018.00209
|
| 56 |
Sael Casas‐Grajales, Karina Reyes‐Gordillo, Carlos M. Cerda‐García‐Rojas, Víctor Tsutsumi, M. Raj Lakshman, Pablo Muriel. Rebaudioside A administration prevents experimental liver fibrosis: an in vivo and in vitro study of the mechanisms of action involved. Journal of Applied Toxicology 2019; 39(8): 1118 doi: 10.1002/jat.3797
|
| 57 |
Yong-mei Liu, Shuo Cong, Zhuo Cheng, Ya-xin Hu, Yu Lei, Li-li Zhu, Xue-ke Zhao, Mao Mu, Bao-fang Zhang, Lin-da Fan, Lei Yu, Ming-liang Cheng. Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway. European Journal of Pharmacology 2020; 876: 172946 doi: 10.1016/j.ejphar.2020.172946
|
| 58 |
Erika Ramos-Tovar, Pablo Muriel. Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver. Antioxidants 2020; 9(12): 1279 doi: 10.3390/antiox9121279
|
| 59 |
Yanfei Du, Jun Ma, Yu Fan, Xinyu Wang, Shuzhan Zheng, Jian Feng, Jiafu Li, Zhongcai Fan, Guang Li, Qiang Ye, Rosalba Parenti. Naringenin: A Promising Therapeutic Agent against Organ Fibrosis. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/1210675
|
| 60 |
Kübra Uçar, Zeynep Göktaş. Biological activities of naringenin: A narrative review based on in vitro and in vivo studies. Nutrition Research 2023; 119: 43 doi: 10.1016/j.nutres.2023.08.006
|
| 61 |
Ze-jiang Ma, Shan-shan Yue, Bo-yang Qin, Yi-tong Hu, An-kang Peng, Qin-Yu Wang, Rong Qi. Naringenin ameliorates MASH fibrosis via regulating TAK1/MAPK/FoxO3a-mediated apoptosis in the activated hepatic stellate cells. Biochemical and Biophysical Research Communications 2024; 734: 150732 doi: 10.1016/j.bbrc.2024.150732
|
| 62 |
Qichao Hu, Wenwen Zhang, Feng Wei, Meilan Huang, Mengyao Shu, Dan Song, Jianxia Wen, Jundong Wang, Qing Nian, Xiao Ma, Jinhao Zeng, Yanling Zhao. Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization. Phytotherapy Research 2024; 38(1): 280 doi: 10.1002/ptr.8043
|
| 63 |
Yan Lin, Dan Tan, Qianna Kan, Zhen Xiao, Zhiyan Jiang. The Protective Effect of Naringenin on Airway Remodeling afterMycoplasma PneumoniaeInfection by Inhibiting Autophagy-Mediated Lung Inflammation and Fibrosis. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/8753894
|
| 64 |
Erika Ramos-Tovar, Pablo Muriel. Antioxidants. Vitamins and Hormones 2023; 121: 271 doi: 10.1016/bs.vh.2022.09.006
|
| 65 |
Bolin Zhao, Kai Liu, Xing Liu, Qiuxia Li, Zhibei Li, Jingjing Xi, Fan Xie, Xiaofang Li. Plant‐derived flavonoids are a potential source of drugs for the treatment of liver fibrosis. Phytotherapy Research 2024; 38(6): 3122 doi: 10.1002/ptr.8193
|
| 66 |
Sael Casas‐Grajales, Diana Alvarez‐Suarez, Erika Ramos‐Tovar, Laura Dayana Buendía‐Montaño, Karina Reyes‐Gordillo, Javier Camacho, Víctor Tsutsumi, M. Raj Lakshman, Pablo Muriel. Stevioside inhibits experimental fibrosis by down‐regulating profibrotic Smad pathways and blocking hepatic stellate cell activation. Basic & Clinical Pharmacology & Toxicology 2019; 124(6): 670 doi: 10.1111/bcpt.13194
|
| 67 |
Lorena Rosas-Martínez, Rafael Rodríguez-Muñoz, María del Carmen Namorado-Tonix, Fanis Missirlis, Leonardo del Valle-Mondragón, Alicia Sánchez-Mendoza, José L. Reyes-Sánchez, Luz Graciela Cervantes-Pérez. Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress. Life Sciences 2021; 268: 119003 doi: 10.1016/j.lfs.2020.119003
|
| 68 |
Yi Peng, Xiaoyan Hao, Yuan Guo, Xueqin Zhang, Yang Li, Yanmei Ma, Juan Wang. High quality nursing based on childlike interest in children with cleft lip and palate: application assessment after operation. BMC Oral Health 2021; 21(1) doi: 10.1186/s12903-021-01893-6
|
| 69 |
Muhammad Fayyaz ur Rehman, Aima Iram Batool, Rahman Qadir, Mehwish Aslam. A Centum of Valuable Plant Bioactives. 2021; : 403 doi: 10.1016/B978-0-12-822923-1.00027-3
|
| 70 |
Marta Alegret, Juan Carlos Laguna, Núria Roglans. Coffee in Health and Disease Prevention. 2025; : 553 doi: 10.1016/B978-0-443-13868-3.00001-6
|
| 71 |
Haifeng Wang, Yang Li, Na Wu, Chunmei Lv, Yishu Wang. P4HB regulates the TGFβ/SMAD3 signaling pathway through PRMT1 to participate in high glucose-induced epithelial-mesenchymal transition and fibrosis of renal tubular epithelial cells. BMC Nephrology 2024; 25(1) doi: 10.1186/s12882-024-03733-5
|
| 72 |
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Víctor Tsutsumi, Pablo Muriel. The antioxidant and anti-inflammatory activities of caffeine effectively attenuate nonalcoholic steatohepatitis and thioacetamide-induced hepatic injury in male rats. Canadian Journal of Physiology and Pharmacology 2023; 101(3): 147 doi: 10.1139/cjpp-2022-0303
|
| 73 |
Siyu Zhao, Xin Chen, Rui Tan, Xiaoqing Wu, Hezhong Jiang. Research Progress in Natural Products against Liver Fibrosis. The Natural Products Journal 2025; 15(4) doi: 10.2174/0122103155293866240522085229
|
| 74 |
Dunia Margarita Medina-Buelvas, Elizabet Estrada-Muñiz, Miriam Rodríguez-Sosa, Mineko Shibayama, Libia Vega. Increased heart fibrosis and acute infection in a murine Chagas disease model associated with organophosphorus pesticide metabolite exposure. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-54218-7
|
| 75 |
Zhen Li, Jun-Feng Zhu, Hao Ouyang. Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress. World Journal of Hepatology 2023; 15(10): 1091-1108 doi: 10.4254/wjh.v15.i10.1091
Abstract(703) |
Core Tip(674) |
Full Article(HTML)(3195)
|
Full Article with Cover (PDF)-3155K(136)
|
Full Article (Word)-1498K(52)
|
Audio-757K(10)
|
Peer-Review Report-229K(73)
|
Answering Reviewers-113K(67)
|
Full Article (PDF)-2189K(175)
|
Full Article (XML)-279K(85)
|
Times Cited (7)
|
Total Visits (8382)
|
Open
|